Findings aid antiviral drug discovery
Many viral infections, such as the common cold, cause mild illnesses that the body’s immune system eventually defeats. But when viruses cause severe disease, doctors have few options for effective treatment.
Studying mice with a variety of viral infections, scientists at Washington University School of Medicine in St. Louis have demonstrated a way to dial up the body’s innate immune defenses while simultaneously attacking a protein that many viruses rely on to replicate.
The findings, published Oct. 19 in Nature Immunology, reveal previously unknown weapons in the body’s antiviral immune arsenal and provide guidelines for designing drugs that could be effective against a broad range of viruses. The strategy involves enhancing the body’s interferon signaling system, long understood to be a vital part of antiviral defenses.
“We’ve discovered a new component of the interferon system,” said senior author Michael J. Holtzman, MD, the Selma and Herman Seldin Professor of Medicine. “It does something that other components don’t do, and it works on both sides of the fence: It dials up the body’s internal genes that fight viruses, and it attacks viral proteins directly.”
Holtzman and lead author Yong Zhang, PhD, an instructor in pulmonary medicine, suspect that the researchers’ one-two punch against the virus may explain the large difference in survival rates between control mice and mice genetically engineered to have increased signaling in their interferon systems.
When infected with encephalomyocarditis virus, which causes severe damage to vital organs including the brain, heart and pancreas, 97 percent of the genetically engineered mice survived, compared with none of the control mice. Even when the concentration of the injected virus was increased 100-fold, 82 percent of the genetically altered mice survived. And at 100-fold lower concentrations, all genetically engineered mice survived the infection, compared with only 25-28 percent of the control mice.
Holtzman pointed out that past research by other groups has shown that increasing the amount of interferon directly results in some improvements in fighting viruses, but not to the same extent as the current work. In addition, more modest improvements shown by other investigators usually are accompanied by autoimmune problems resulting from the chronically activated immune response. Despite the strong antiviral immune response seen in the new study, Holtzman and his colleagues reported no evidence of autoimmune disease in these mice.
The Latest on: Antiviral immune response
via Google News
The Latest on: Antiviral immune response
- Antiviral T cells safe and effective for treating debilitating complication common after stem cell transplantson April 30, 2021 at 1:39 pm
A Phase II trial led by researchers at The University of Texas MD Anderson Cancer Center found that BK virus (BKV)-specific T cells from healthy donors were safe and effective as an off-the-shelf ...
- Prospects for durable immune control of SARS-CoV-2 and prevention of reinfectionon April 29, 2021 at 8:59 am
The duration of immunity to coronavirus disease 2019 (COVID-19) from prior infection and longer-term risk of reinfection are currently unclear. Cromer and colleagues discuss the immune control of ...
- How SARS-CoV-2 hijacks human cells to evade immune systemon April 29, 2021 at 6:46 am
Researchers at University of California San Diego School of Medicine have discovered one way in which SARS-CoV-2, the coronavirus that causes COVID-19, hijacks human cell machinery to blunt the immune ...
- Mucosal epithelial cells: the initial sentinels and responders controlling and regulating immune responses to viral infectionson April 28, 2021 at 5:00 pm
Model of epithelial cells as initial responders that control and regulate immune responses to viral infections. A Upon viral infection, mucosal epithelial cells recognize viral PAMPs, activate various ...
- Study reveals the role of lncRNAs in immune dysfunction during severe COVID-19on April 27, 2021 at 9:27 pm
Scientific studies rarely focus on long non-coding RNA molecules (lncRNAs), even though they potentially regulate several diseases. The role of several lncRNAs in anti-viral inflammatory response ...
- Dolphins' genetic response to viruson April 27, 2021 at 7:30 am
Flinders University researchers have sequenced the genomes of dolphins, revealing variations that may influence their deadly immune response to a measles related virus.
- Biodesix Announces Presentation on SARS-CoV-2 Neutralizing Antibody Testing for Individual Vaccine Response and Commercial Launch Planson April 26, 2021 at 1:01 pm
Despite significant research and clinical advances made to combat the SARS-CoV-2 virus, the emergence of new variants and community outbreaks are of continued concern. Biodesix and GenScript have come ...
- Gut as viral reservoir: lessons from gut viromes, HIV and COVID-19on April 24, 2021 at 5:00 pm
The gut microbiota is composed of bacteria, fungi and viruses.1–3 While the presence and composition of the bacteriome have been extensively studied in recent years, the ‘dark matter’ of microbiomes ...
- Vaccines Benefit Those Who Have Had COVID-19, Contrary to Viral Postson April 24, 2021 at 8:40 am
There is no evidence that vaccines could cause harm to people who already have been infected with SARS-CoV-2 or have become ill with the disease COVID-19. On the contrary, recent studies show the ...
- Researchers examine antiviral responses in children infected with COVID-19 in South Brazilon April 21, 2021 at 4:52 am
New research has been published that focuses on the characterization of innate and adaptive immune responses in adult patients with different degrees of severity and also in pediatric patients with ...
via Bing News